Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted therapy for adolescents with treatment-resistant PTSD
NL-OMON61516Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of midomafetamine, sponsored by Amsterdam University Medical Center. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
midomafetamine
Beyond the preview
Go deeper on NL-OMON61516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61516.